(IN BRIEF) The University of Liverpool has secured £1.3m in funding to support the UK Government's Fleming Fund Fellowship Programme,…
(IN BRIEF) Sanofi's experimental CD40L antibody, frexalimab, demonstrates encouraging results in a 48-week phase 2 study for relapsing multiple sclerosis…
(IN BRIEF) Novartis revealed promising data from the ALITHIOS open-label extension study, highlighting the enduring effectiveness of Kesimpta® (ofatumumab) in…
(IN BRIEF) AstraZeneca's IMPACT CKD model predicts a significant increase in chronic kidney disease (CKD) across eight countries, with up…
(IN BRIEF) Bosch and Randox Laboratories Ltd. have forged a strategic partnership aimed at transforming molecular diagnostics with a focus…
(IN BRIEF) The European Bank for Reconstruction and Development (EBRD) has provided a €22 million loan to Ukrainian pharmaceutical giant…
(IN BRIEF) Royal Philips announces the final agreement on a consent decree for its subsidiary, Philips Respironics, with the US…
(IN BRIEF) A recent study conducted by researchers from the Universities of Bristol and Bath, King’s College London, and University…
(IN BRIEF) A study conducted at the University of Helsinki under the DyslexiaBaby project reveals that infants' neural responses to…
(IN BRIEF) A groundbreaking study led by researchers from the University of Exeter, the Wellcome Sanger Institute, and the University…